-
1دورية أكاديمية
المؤلفون: Heintel, DanielAff1, IDs12254021007764_cor1
المصدر: memo - Magazine of European Medical Oncology: An International Journal for Oncology and Haematology Professionals. 15(1):49-52
-
2دورية أكاديمية
المؤلفون: Maria Dimou, Theodoros Iliakis, Vasileios Paradalis, Aikaterini Bitsani, Marie‐Christine Kyrtsonis, Panayiotis Panayiotidis
المصدر: Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
مصطلحات موضوعية: CLL/SLL, MRD negativity, skin nodules, time‐limited treatment, venetoclax, Medicine, Medicine (General), R5-920
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2050-0904
-
3
المؤلفون: Garrett Chi-lai Ho, Cheong Ngai, Shaji Kumar, Chor Sang Chim, Sirong Chen
المصدر: Therapeutic Advances in Hematology
مصطلحات موضوعية: Oncology, 3-weekly daratumumab, Series (stratigraphy), medicine.medical_specialty, business.industry, MRD Negativity, Daratumumab, Hematology, Newly diagnosed, Advances in Multiple Myeloma, medicine.disease, Minimal residual disease, quadruplet induction, 11c acetate, MRD negativity, Internal medicine, hemic and lymphatic diseases, newly diagnosed multiple myeloma, medicine, 11C-Acetate PET, Case Series, business, Complete response, Multiple myeloma
-
4Measurable residual disease in multiple myeloma and light chain amyloidosis: more than meets the eye
المؤلفون: Iuliana Vaxman, Morie A. Gertz
المصدر: Leukemia & Lymphoma. 62:1544-1553
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Neoplasm, Residual, MRD Negativity, Disease, Immunoglobulin light chain, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Immunoglobulin Light-chain Amyloidosis, Multiple myeloma, Predictive marker, business.industry, Amyloidosis, Hematology, medicine.disease, Response to treatment, Highly sensitive, body regions, Treatment Outcome, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, Multiple Myeloma, business, 030215 immunology
-
5
المؤلفون: Panayiotis Panayiotidis, Marie-Christine Kyrtsonis, Maria Dimou, Vasileios Paradalis, Aikaterini Bitsani, Theodoros Iliakis
المصدر: Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Clinical Case Reportsمصطلحات موضوعية: Medicine (General), Mitotic index, venetoclax, Venetoclax, business.industry, MRD Negativity, Chronic lymphocytic leukemia, food and beverages, General Medicine, medicine.disease, chemistry.chemical_compound, R5-920, MRD negativity, chemistry, Clinical Images, Obinutuzumab, Clinical Image, CLL/SLL, Cancer research, medicine, Medicine, time‐limited treatment, skin nodules, business
-
6
المؤلفون: Vijaya Raj Bhatt, Shristi Upadhyay Banskota, Nabin Khanal
المصدر: Clin Pharmacol Ther
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Neoplasm, Residual, MRD Negativity, medicine.medical_treatment, Clinical Decision-Making, Antineoplastic Agents, Disease, 030226 pharmacology & pharmacy, Article, law.invention, 03 medical and health sciences, 0302 clinical medicine, Drug Development, Predictive Value of Tests, law, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Drug Discovery, Biomarkers, Tumor, medicine, Humans, Pharmacology (medical), Molecular Targeted Therapy, Precision Medicine, Drug Approval, Polymerase chain reaction, Pharmacology, Chemotherapy, business.industry, Myeloid leukemia, Minimal residual disease, Mutational analysis, Leukemia, Myeloid, Acute, Treatment Outcome, Molecular Diagnostic Techniques, Drug development, 030220 oncology & carcinogenesis, business
-
7
المؤلفون: Katie Culos, Robert F. Cornell, Salyka Sengsayadeth, Michael Byrne, Madan Jagasia, Stacey Goodman, Evonne McArthur, Bipin N. Savani, Brian G. Engelhardt, Dilan A Patel, Ragisha Gopalakrishnan, Wichai Chinratanalab, Claudio A. Mosse, Adetola A. Kassim
المصدر: Bone Marrow Transplant
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Neoplasm, Residual, MRD Negativity, Disease-Free Survival, Article, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Multiparameter flow cytometry, Lenalidomide, Multiple myeloma, Transplantation, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Minimal Residual Disease Negativity, medicine.disease, Minimal residual disease, Treatment Outcome, 030220 oncology & carcinogenesis, Multiple Myeloma, business, 030215 immunology, medicine.drug
-
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9
المؤلفون: Kaichi Nishiwaki, Shingo Yano, Kazuhito Suzuki
المصدر: Cancers
Cancers, Vol 13, Iss 4867, p 4867 (2021)مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, autologous stem cell transplantation, medicine.drug_class, MRD Negativity, T cell, Review, Monoclonal antibody, Autologous stem-cell transplantation, Internal medicine, hemic and lymphatic diseases, medicine, immunomodulatory drug, Multiple myeloma, RC254-282, business.industry, immune environment, proteasome inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Minimal residual disease, Chimeric antigen receptor, body regions, multiple myeloma, medicine.anatomical_structure, monoclonal antibody, Proteasome inhibitor, minimal residual disease, business, medicine.drug
-
10
المؤلفون: Nisha Thiagarajah, Richard Dillon, Nigel H. Russell, Amanda F. Gilkes, Ashish Bajel, Ing Soo Tiong, Andrew H. Wei, Claire Hemmaway, Abin Thomas, Nicola E. Potter, Matthew Smith, James Anton Kuzich, Chung H. Kok, Adam Ivey
المصدر: Blood. 136:25-27
مصطلحات موضوعية: Chemotherapy, medicine.medical_specialty, business.industry, MRD Negativity, medicine.medical_treatment, Immunology, Complete remission, Cell Biology, Hematology, Transcript level, Biochemistry, Treatment efficacy, Natural history, Internal medicine, Medicine, In patient, Relapse risk, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bfdce1d2846f0299fd9ee3362b121572
https://doi.org/10.1182/blood-2020-140296